Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

SHE:300318 Revenue

Beijing Bohui Innovation Biotechnology Group had revenue of 230.60M CNY in the quarter ending September 30, 2026, with 2.58% growth. This brings the company's total for the last twelve months to 821.94M, down -1.49% year-over-year. In the year 2025, Beijing Bohui Innovation Biotechnology Group had annual revenue of 824.58M, down -3.18%. That makes Beijing Bohui Innovation Biotechnology Group the 21,110th largest company in the world by revenue and 3,881st in China.

• Revenue (ttm): 821.94M
• Revenue Growth: -1.49%
• P/S Ratio: 4.59
• Revenue / Employee: 378.78K
• Employees: 2,170
• Market Cap: 3.77B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biological Products 586.43M 71.1%
• Inspection and Testing Division 238.15M 28.9%

By Geography

Chart

• East China 207.64M 25.2%
• Northern China 152.32M 18.5%
• South China Region 139.00M 16.9%
• Central 99.91M 12.1%
• Foreign 93.92M 11.4%
• South-West China 83.13M 10.1%
• North-East China 28.01M 3.4%
• North-West China 20.65M 2.5%

Fiscal year ended Dec 31, 2025 See the full SHE:300318 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	824.58M	-27.12M	-3.18%
Dec 31, 2024	851.69M	-193.73M	-18.53%
Dec 31, 2023	1.05B	249.50M	31.35%
Jan 1, 2023	795.93M	81.18M	11.36%
Jan 1, 2022	714.75M	-23.97M	-3.24%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error